Guided mode resonant filter biosensor using a linear grating surface structure
View Patent ↗Methods and compositions are provided for detecting biomolecular interactions. The use of labels is not required and the methods can be performed in a high-throughput manner. The invention also provides optical devices useful as narrow band filters.
1. A biosensor comprising:
(a) a one-dimensional grating surface structure comprised of a material having a low refractive index;
(b) a high refractive index material layer that is applied on top of the low refractive index one-dimensional grating layer; and
(c) one or more specific binding substances immobilized on a surface of the high refractive index layer opposite of the one-dimensional grating surface structure comprised of a material having a low refractive index; wherein the one or more specific binding substances are bound to their binding partners and wherein one or more specific binding substances and their binding partners are detection label-free,
wherein, when the biosensor is illuminated a resonant grating effect is produced on a reflected radiation spectrum, and wherein cross-section of the one-dimensional grating is less than the wavelength of the resonant grating effect.
2. The biosensor of claim 1 , wherein the cross-sectional profile of the one-dimensional grating is triangular, sinusoidal, trapezoidal, rectangular, v-shaped, u-shaped, upside-down u-shaped, upside-down v-shaped, stepped or square.
3. The biosensor of claim 1 , wherein a narrow band of optical wavelengths is reflected from the biosensor when the biosensor is illuminated with a broad band of optical wavelengths.
4. The biosensor of claim 1 , wherein the low refractive index material comprises glass, plastic, polymer, or epoxy.
5. The biosensor of claim 1 , wherein the high refractive index material is selected from the group consisting of zinc sulfide, titanium dioxide, indium tin oxide, tantalum oxide, and silicon nitride.
6. The biosensor of claim 1 , wherein the one-dimensional grating has a period of about 0.01 microns to about 1 micron and a depth of about 0.01 microns to about 1 micron.
7. The biosensor of claim 1 , wherein the one or more specific binding substances are arranged in an array of distinct locations.
8. The biosensor of claim 7 , wherein the distinct locations define a microarray spot of about 10-500 microns in diameter.
9. The biosensor of claim 1 , wherein the one or more specific binding substances are immobilized on the high refractive index material by physical adsorption or by chemical binding.
10. The biosensor of claim 1 , wherein the one or more specific binding substances are selected from the group consisting of nucleic acids, polypeptides, antigens, polyclonal antibodies, monoclonal antibodies, single chain antibodies (scFv), F(ab) fragments, F(ab′) 2 fragments, Fv fragments, small organic molecules, cells, viruses, bacteria, polymers, peptide solutions, protein solutions, chemical compound library solutions, single-stranded DNA solutions, double-stranded DNA solutions, RNA solutions, and biological samples.
11. The biosensor of claim 10 , wherein the biological sample is selected from the group consisting of blood, plasma, serum, gastrointestinal secretions, homogenates of tissues or tumors, synovial fluid, feces, saliva, sputum, cyst fluid, amniotic fluid, cerebrospinal fluid, peritoneal fluid, lung lavage fluid, semen, lymphatic fluid, tears, and prostatitc fluid.
12. The biosensor of claim 1 , wherein the binding partners are selected from the group consisting of nucleic acids, polypeptides, antigens, polyclonal antibodies, monoclonal antibodies, single chain antibodies (scFv), F(ab) fragments, F(ab′) 2 fragments, Fv fragments, small organic molecules, cells, vimses, bacteria, polymers, peptide solutions, protein solutions, chemical compound library solutions, single-stranded DNA solutions, double-stranded DNA solutions, RNA solutions and biological samples.
13. The biosensor of claim 12 , wherein the biological sample is selected from the group consisting of blood, plasma, serum, gastrointestinal secretions, homogenates of tissues or tumors, synovial fluid, feces, saliva, sputum, cyst fluid, amniotic fluid, cerebrospinal fluid, peritoneal fluid, lung lavage fluid, semen, lymphatic fluid, tears, and prostatitc fluid.
14. A liquid-containing vessel comprising a biosensor as an internal surface, wherein the biosensor comprises:
(a) a one-dimensional grating surface structure comprised of a material having a low refractive index;
(b) a high refractive index material layer that is applied on top of the low refractive index one-dimensional grating layer; and
(c) one or more specific binding substances immobilized on a surface of the high refractive index layer opposite of the one-dimensional grating surface structure comprised of a material having a low refractive index; wherein the one or more specific binding substances are bound to their binding partners and wherein one or more specific binding substances and their binding partners are detection label-free,
wherein, when the biosensor is illuminated a resonant grating effect is produced on a reflected radiation spectrum, and wherein cross-section of the one-dimensional grating is less than the wavelength of the resonant grating effect.
15. The liquid-containing vessel of claim 14 , wherein the vessel is selected from the group consisting of a microtiter plate, a test tube, a petri dish and a microfluidic channel.